Doyle Janeen Noel 4
4 · Janux Therapeutics, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Transactions
- Award
Stock option (right to buy)
2025-06-02+154,000→ 154,000 totalExercise: $25.01Exp: 2035-06-01→ Common Stock (154,000 underlying) - Award
Common Stock
2025-06-02+44,000→ 44,000 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on June 1, 2026.
- [F2]25% of the shares subject to the option vest on May 14, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.